U.S. and China Asthma and COPD Drugs Market: Snapshot

The U.S. and China market for asthma and chronic obstructive pulmonary disease (COPD) drugs is expected to exhibit growth at a steady pace in the next few years. Factors such as a significant rise prevalence of COPD and asthma in these two countries, advancements in diagnostic methods, and rising awareness among ... Read more

The asthma and COPD drugs market in US and China is expected to show a consolidated competitive landscape. In 2015, the leading players within the US and China asthma and COPD drugs Market accounted for 64% of the total Market, according to a recent research report by transparency market research TMR. The names of the leading players within the US and China asthma and COPD drugs market are: Merck ... Read more

Opportunities in the Asthma and COPD Drugs Market has evolved through a number of stages and Lucintel found its future to be promising. Global Asthma and COPD Drugs Market is expected to reach $40.8 billion by 2030 with a CAGR of 4.3%.

Features of the Global Asthma and COPD Drugs Market ... Read more